Wonderful! @drsunad @CU_PSCCM paper on potential #metformin therapy for #IPF out now. @drsunad recently joined @CUAnschutz @CUMedicalSchool from @UABPulmonary. @KaminskiMed @DKNYPitt @IPFdoc @3LakesPartners @PFFORG @ATS_RCMB @m_konigshoff @KambezBenam http
RT @NatureMedicine: Metformin reverses established lung #fibrosis in a bleomycin model in mice: https://t.co/6my883uvyk https://t.co/3BUHhf…
RT @NatureMedicine: Metformin reverses established lung #fibrosis in a bleomycin model in mice: https://t.co/6my883uvyk https://t.co/3BUHhf…
RT @NatureMedicine: Metformin reverses established lung #fibrosis in a bleomycin model in mice: https://t.co/6my883uvyk https://t.co/3BUHhf…
RT @NatureMedicine: Metformin reverses established lung #fibrosis in a bleomycin model in mice: https://t.co/6my883uvyk https://t.co/3BUHhf…
RT @NatureMedicine: Metformin reverses established lung #fibrosis in a bleomycin model in mice: https://t.co/6my883uvyk https://t.co/3BUHhf…
Congrats @drsunad! https://t.co/3fza7NqX9g
RT @NatureMedicine: Metformin reverses established lung #fibrosis in a bleomycin model in mice: https://t.co/6my883uvyk https://t.co/3BUHhf…
Metformin reverses established lung #fibrosis in a bleomycin model in mice: https://t.co/6my883uvyk https://t.co/3BUHhfnSVu
RT @KaminskiMed: Will Metformin be magic bullet for #IPF ? I’d definitely give it a Trial (prospective, double blind randomized controlled,…
RT @KaminskiMed: Will Metformin be magic bullet for #IPF ? I’d definitely give it a Trial (prospective, double blind randomized controlled,…
RT @philippefroguel: A French gift to medicine and health 🇫🇷(glucophage/metformin) https://t.co/ea3aXU5rbj
Исследователи из Университета Алабамы в Бирмингеме впервые продемонстрировали, что установленный фиброз легких может быть обратим благодаря использованию лекарственной терапии, нацеленной на метаболизм клеток. https://t.co/KBLsiKJzKH
RT @SBurtey: La metformine, un futur traitement de la fibrose pulmonaire? https://t.co/JCoaGRsC25
RT @KaminskiMed: Will Metformin be magic bullet for #IPF ? I’d definitely give it a Trial (prospective, double blind randomized controlled,…
La metformine, un futur traitement de la fibrose pulmonaire? https://t.co/JCoaGRsC25
RT @KaminskiMed: Will Metformin be magic bullet for #IPF ? I’d definitely give it a Trial (prospective, double blind randomized controlled,…
RT @KaminskiMed: Will Metformin be magic bullet for #IPF ? I’d definitely give it a Trial (prospective, double blind randomized controlled,…
Will Metformin be magic bullet for #IPF ? I’d definitely give it a Trial (prospective, double blind randomized controlled, etc) & our results show AMPK/PGC1A is a #TARGET In #PulmonaryFibrosis . KUDOS @NatureMedicine @uabmedicine #MustRead #WednesdayWi
RT @AmSciMag: Researchers are still finding new uses for metformin, the ubiquitous diabetes drug that took a convoluted route to become the…
RT @DanielJDrucker: There are very few diseases that do not bow to the emperor metformin in preclinical studies. After 75 years and extensi…
Researchers are still finding new uses for metformin, the ubiquitous diabetes drug that took a convoluted route to become the standard of care. https://t.co/Bqojhidk3J ($) Now, metformin reverses established lung fibrosis in a bleomycin model (in mice) ht
A French gift to medicine and health 🇫🇷(glucophage/metformin) https://t.co/ea3aXU5rbj
RT @DanielJDrucker: There are very few diseases that do not bow to the emperor metformin in preclinical studies. After 75 years and extensi…
Interesting study suggests AMPK activation reverses TGF beta induced molecular markers in lung fibroblasts and metformin therapeutically resolves fibrosis in bleomycin induced lung fibrosis mouse model, possibly through AMPK activation. https://t.co/vqWV05
RT @DanielJDrucker: There are very few diseases that do not bow to the emperor metformin in preclinical studies. After 75 years and extensi…
RT @DanielJDrucker: There are very few diseases that do not bow to the emperor metformin in preclinical studies. After 75 years and extensi…
RT @DanielJDrucker: There are very few diseases that do not bow to the emperor metformin in preclinical studies. After 75 years and extensi…
RT @DanielJDrucker: There are very few diseases that do not bow to the emperor metformin in preclinical studies. After 75 years and extensi…
RT @PaulHumpa: Metformin reverses established lung fibrosis in a bleomycin model https://t.co/31E775ZTqJ
Metformin reverses established lung fibrosis❗ https://t.co/kE3QNl6Jl9 scientists at the University of Alabama at Birmingham have shown—for the first time—that established lung fibrosis can be reversed using a drug treatment that targets cell metabolism❗ h
RT @DanielJDrucker: There are very few diseases that do not bow to the emperor metformin in preclinical studies. After 75 years and extensi…
RT @DanielJDrucker: There are very few diseases that do not bow to the emperor metformin in preclinical studies. After 75 years and extensi…
"Told you so," is what I'm sure @rtnarch is thinking right about now... @matthewherper https://t.co/yGtkFpZz61
RT @DanielJDrucker: There are very few diseases that do not bow to the emperor metformin in preclinical studies. After 75 years and extensi…
RT @DanielJDrucker: There are very few diseases that do not bow to the emperor metformin in preclinical studies. After 75 years and extensi…
RT @ContinuumAEP: #NatureMedicine Metformin reverses established lung fibrosis in a bleomycin model https://t.co/XjADi1cmSc
RT @DanielJDrucker: There are very few diseases that do not bow to the emperor metformin in preclinical studies. After 75 years and extensi…
RT @DanielJDrucker: There are very few diseases that do not bow to the emperor metformin in preclinical studies. After 75 years and extensi…
RT @DanielJDrucker: There are very few diseases that do not bow to the emperor metformin in preclinical studies. After 75 years and extensi…
Metformin reverses established lung fibrosis in a bleomycin model https://t.co/31E775ZTqJ
Metformin reverses established lung fibrosis in a bleomycin model https://t.co/AEHbMBWNEO
RT @DanielJDrucker: There are very few diseases that do not bow to the emperor metformin in preclinical studies. After 75 years and extensi…
RT @DanielJDrucker: There are very few diseases that do not bow to the emperor metformin in preclinical studies. After 75 years and extensi…
RT @DanielJDrucker: There are very few diseases that do not bow to the emperor metformin in preclinical studies. After 75 years and extensi…
Metformin reverses established lung fibrosis in a bleomycin model https://t.co/JXmddejD8U https://t.co/eRdx83qzmJ
There are very few diseases that do not bow to the emperor metformin in preclinical studies. After 75 years and extensive clinical use, will registration studies for therapeutic indications other than #diabetes be forthcoming? #cancer #everything https://t
#NatureMedicine Metformin reverses established lung fibrosis in a bleomycin model https://t.co/XjADi1cmSc